Article
Polymorphism Gln27Glu of β2 Adrenergic Receptors in Patients with Ischaemic Cardiomyopathy.
Current vascular pharmacology - 1 Jan 2018
Metaxa Sofia, Missouris Constantinos, Mavrogianni Depy, Miliou Antigoni, Oikonomou Evangelos, Toli Eirini, Kormali Lambrini, Vlismas Antonios, Drakakis Peter, Tousoulis Dimitris
Abstract excerpt
BACKGROUND: Polymorphisms of the Adrenergic Receptors (ARs) might affect the development and progression of Heart Failure (HF) and the response to treatment with β-blockade therapy. OBJECTIVE: To examine the role of the Gln27Glu polymorphism of β2-AR in HF development and to assess the hypothesis that Gln27Glu is associated with coronary artery disease in patients with ischaemic HF. METHODS: In this case control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
